Second, the systemic levels of PRKACA have been observed to be elevated in patients of various types of cancers, including lung cancer, and thus PRKACA in blood has been proposed as a potential cancer biomarker [128,129,130,131,132]. This evidence concerns the gene PRKACA and cancer.